Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 101-110 of 171 for Prostate cancer

Edit search filters
  1. Staging Prostate Cancer With Hybrid C11-Choline PET/MR And MpMRI

    Scottsdale/Phoenix, AZ

  2. Bicalutamide And Raloxifene Hydrochloride In Treating Patients With Prostate Cancer Undergoing Surgery

    Scottsdale/Phoenix, AZ

  3. A Study Of Niraparib Combination Therapies For The Treatment Of Metastatic Castration-Resistant Prostate Cancer

    Jacksonville, FL

  4. Trial Of Neoadjuvant Enoblituzumab Vs SOC In Men With High-Risk Localized Prostate Cancer

    Rochester, MN

  5. A Phase I Study Of [225Ac]-AZD2284 In Patients With Metastatic Castration-Resistant Prostate Cancer

    Rochester, MN

  6. Phase I Cabazitaxel, Mitoxantrone, And Prednisone Metastatic Castration-Resistant Prostate Cancer

    Scottsdale/Phoenix, AZ

  7. Study Of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer

    Rochester, MN

  8. A Study To Evaluate Androgen-Deprivation Therapy And Radiation Therapy In Treating Patients With Prostate Cancer

    Eau Claire, WI

  9. A Study Of Apalutamide (ARN-509) In Men With Non-Metastatic Castration-Resistant Prostate Cancer

    Jacksonville, FL

  10. A Study To Evaluate Hypofractionated Proton Therapy Or IMRT For Recurrent, Oligometastatic Prostate Cancer

    Rochester, MN

.

Mayo Clinic Footer